Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction

@article{Trivedi2015SingleblindPC,
  title={Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction},
  author={Vrinda Trivedi and Mc Satia and Ann Barnes Deschamps and V{\'e}ronique Maquet and RB Shah and PH Zinzuwadia and JV Trivedi},
  journal={Nutrition Journal},
  year={2015},
  volume={15}
}
BackgroundChitosan is a dietary fibre which acts by reducing fat absorption and thus used as a means for controlling weight. Weight loss clinical trial outcomes, however, have contradictory results regarding its efficacy. The primary objective of the present study was to evaluate the efficacy and safety of a chitosan from fungal origin in treatment of excess weight in the absence of dietary restrictions.MethodsA phase IV, randomised, multicentre, single-blind, placebo-controlled, clinical study… 
A Meta-Analysis on Randomised Controlled Clinical Trials Evaluating the Effect of the Dietary Supplement Chitosan on Weight Loss, Lipid Parameters and Blood Pressure
TLDR
It is concluded that the usage of chitosan as a dietary supplement can lead to a slight short- and medium-term effect on weight loss and to the improvement of serum lipid profile and cardiovascular factors.
The effects of chitosan supplementation on body weight and body composition: a systematic review and meta-analysis of randomized controlled trials
TLDR
Evidence is provided that chitosan consumption might be a useful adjunctive pharmacological therapeutic tool for body weight management particularly in overweight/obese participants and well-constructed clinical trials that target body weight and body composition as their primary outcomes are needed.
Lipid‐Modifying Effects of Chitosan Supplementation in Humans: A Pooled Analysis with Trial Sequential Analysis
TLDR
Current evidence indicates daily chitosan supplementation as a candidate for therapeutic lipid management strategies, and the cumulative Z-curve crossed the trial sequential monitoring boundary for benefit providing conclusive evidence for the benefit of chitOSan.
Regular Consumption of Lipigo® Promotes the Reduction of Body Weight and Improves the Rebound Effect of Obese People Undergo a Comprehensive Weight Loss Program
TLDR
The regular consumption of the product Lipigo® promotes the reduction of body weight and reduces the rebound effect of obese people after 52 weeks (12 months), mainly in obesity type 1, who undergo a comprehensive weight loss program.
Chitosan modifies glycemic levels in people with metabolic syndrome and related disorders: meta-analysis with trial sequential analysis
TLDR
The glucose level of patients who are diabetic and obese/overweight can be improved by supplementation with chitosan for at least 13 weeks at 1.6–3 g per day.
Effects of isolated soluble fiber supplementation on body weight, glycemia, and insulinemia in adults with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials.
TLDR
Isolated soluble fiber supplementation improves anthropometric and metabolic outcomes in overweight and obese adults, thereby indicating that supplementation may improve fiber intake and health in these individuals.
Chitosan alleviated menopausal symptoms and modulated the gut microbiota in estrogen-deficient rats
TLDR
Chitosan was more effective for improving menopausal symptoms than citrus pectin as well as improving the diversity and composition of the gut microbiota, and serum metabolites and SCFA originating from fecal bacteria.
Borassus aethiopum-Fortified Bread Reduces Metabolic Risk Factors among Cardiovascular Disease Outpatients at 37 Military Hospital, Accra: A Pilot Study
TLDR
The Borassus-fortified bread significantly reduced blood pressure and improved lipid profile and other metabolic risk factors among the CVD outpatients studied and its potential in the management of CVDs and other metabolism-related diseases should be looked at.
Beneficial Health Effects of Chitin and Chitosan
TLDR
Scientific literature has been reviewed that demonstrated the beneficial health effects of chitin and chitosan from an immunomodulatory point‐of‐view and various human intervention trials are listed that most clearly demonstrate these effects.
...
...

References

SHOWING 1-10 OF 56 REFERENCES
The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults
TLDR
In this 24-week trial, chitosan treatment did not result in a clinically significant loss of body weight compared with placebo, but effects were small.
Randomized, double-blind trial of chitosan for body weight reduction
TLDR
The above data suggest that chitosan in the administered dosage, without dietary alterations, does not reduce body weight in overweight subjects, and is not incorporated as a major constituent into several over-the-counter remedies.
Evaluating Efficacy of a Chitosan Product Using a Double-Blinded, Placebo-Controlled Protocol
TLDR
Evidence is provided for the efficacy of a chitosan compound to facilitate the depletion of excess body fat under free-living conditions with minimal loss of fat-free or lean body mass.
Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical study
TLDR
The herbal formulation LI85008F (Adipromin) is prepared from commonly used medicinal plants extracts, which provides useful and safe application for weight loss in obese humans and demonstrates potential promise in controlling healthy blood glucose level in obesity linked type 2 diabetes.
A Randomized, Double-Blind, Placebo- Controlled Study Examining the Effects of a Rapidly Soluble Chitosan Dietary Supplement on Weight Loss and Body Composition in Overweight and Mildly Obese Individuals
TLDR
Evaluating the efficacy of a rapidly-soluble chitosan (LipoSan Ultra™) in facilitating weight loss and reducing body fat in overweight and mildly obese individuals consuming a high-fat diet also examines functional changes in gastrointestinal and elimination symptoms caused by supplementation of this compound.
Use of polyglucosamine and physical activity to reduce body weight and dyslipidemia in moderately overweight subjects.
TLDR
Results indicate that PG may improve the effect of the physical training in moderately overweight patients with dyslipidemia and may be of some help in the treatment of MS.
Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes
TLDR
Despite the superior weight loss, sibutramine 15 mg daily did not produce HRQL benefits over placebo when measured with the generic RAND-36 in obese type II diabetes patients.
The effects of chitosan oligosaccharide (GO2KA1) supplementation on glucose control in subjects with prediabetes.
TLDR
In subjects with prediabetes, 12 week supplement with GO2KA1 may help control postprandial glucose compared with control, and the plasma level of HbA1c and the pro-inflammatory cytokines were reduced and plasma adiponectin was increased in the intervention group after the 12 week treatment.
Effects of Chitosan on Plasma Lipids and Lipoproteins
TLDR
A beneficial effect of chitosan is found on LDL subclasses, with a significant increase in LDL-2 particles and a decrease in atherogenic small, dense LDL and whether these findings may affect cardiovascular risk remains to be established in future studies.
Effect of a weight loss intervention on anthropometric measures and metabolic risk factors in pre- versus postmenopausal women
TLDR
Both groups showed comparable weight loss and in postmenopausal women weight loss was associated with a pronounced improvement in metabolic risk factors thereby reducing the prevalence of metabolic syndrome.
...
...